Production (Stage)
Oragenics, Inc.
OGEN
$4.28
$0.7521.25%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.33M | -10.57M | -19.97M | -19.52M | -20.26M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 4.80K | 16.10K |
| Total Amortization of Deferred Charges | 192.90K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 377.90K | 516.00K | 11.25M | 11.30M | 11.31M |
| Change in Net Operating Assets | 2.12M | 1.45M | 1.03M | 992.80K | 689.50K |
| Cash from Operations | -7.65M | -8.60M | -7.68M | -7.21M | -8.25M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 63.70K | 63.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -1.00M | -1.00M | -1.00M |
| Cash from Investing | -- | -- | -1.00M | -936.30K | -936.30K |
| Total Debt Issued | 2.23M | -- | -- | -- | -- |
| Total Debt Repaid | -702.80K | -693.10K | -611.00K | -611.10K | -592.20K |
| Issuance of Common Stock | 7.47M | 6.67M | 6.67M | 3.64M | 2.69M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.99M | 5.98M | 6.06M | 3.03M | 2.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.35M | -2.62M | -2.62M | -5.13M | -7.09M |